REPAMADE V1/0.3 TABLET

Product Description

REPAMADE V1/0.3 TABLET | Repaglinide (1mg) + Voglibose (0.3mg)

Boost your pharmaceutical portfolio with REPAMADE V1/0.3 TABLET, a powerful combination therapy designed for effective management of Type 2 Diabetes Mellitus. This formulation combines Repaglinide (1mg), a fast-acting insulin secretagogue, with Voglibose (0.3mg), an alpha-glucosidase inhibitor, to provide dual-action glucose control by stimulating insulin release and delaying carbohydrate absorption.

Key Benefits:

• Rapid and sustained postprandial blood glucose control

• Improved glycemic management with reduced risk of hypoglycemia

• Enhanced patient compliance due to combined formulation

• Suitable for adjunct therapy alongside diet and exercise

Usage:
Prescribed primarily for Type 2 diabetic patients requiring efficient post-meal blood sugar regulation. REPAMADE V1/0.3 TABLET helps optimize insulin secretion and delays glucose absorption to maintain balanced blood sugar levels.

Why Choose REPAMADE V1/0.3 TABLET?
Ideal for pharmaceutical distributors, retailers, and bulk buyers seeking high-quality antidiabetic solutions. Manufactured under stringent quality standards, REPAMADE ensures efficacy, safety, and consistency critical for large-scale supply in hospitals, clinics, and retail pharmacies.